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PRenal Artery Calcium Is
Independently Associated With Hypertension
Matthew A. Allison, MD, MPH,*† Elizabeth O. Lillie, PHD,† Dominic DiTomasso, BS,‡
C. Michael Wright, MD,† Michael H. Criqui, MD, MPH*†
San Diego, California
Objectives We tested the hypothesis that renal artery calcium (RAC), a marker of atherosclerotic plaque burden, is also sig-
nificantly associated with higher blood pressure levels and a diagnosis of hypertension.
Background In the nonrenal systemic vasculature, atherosclerotic plaque burden has been shown to be significantly associ-
ated with hypertension.
Methods A total of 1,435 consecutive patients were evaluated at a university-affiliated disease prevention center for the
extent of calcified atherosclerosis in the systemic vasculature.
Results The overall prevalence of calcium in either renal artery was 17.1%, with men having a significantly higher preva-
lence (19.0%, 153 of 804) than women (14.7%, 93 of 631) (p  0.03). After adjustment for age and gender,
subjects with a RAC score 0 had a significantly higher prevalence of hypertension (41.2 vs. 29.5, p  0.01). In
a logistic model that adjusted for age, gender, body mass index, percent body fat, diabetes, smoking, dyslipide-
mia, and the extent of calcified atherosclerosis in the nonrenal vasculature, those with any RAC had a signifi-
cantly higher odds ratio (1.61, p  0.01) for hypertension than those with no RAC.
Conclusions The results of this study suggest that the presence of RAC is associated with higher odds for prevalent hyperten-
sion, independent of CVD risk factors and the extent of calcified atherosclerosis in the nonrenal vasculature.
(J Am Coll Cardiol 2007;50:1578–83) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.015l
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olthough the pathophysiology of blood pressure elevation is
ultifactorial, renal mechanisms appear to play a primary role
1). It has been proposed that renal microvascular disease is
he central and unifying pathophysiologic mechanism of
ypertension (HTN) (2). A key component of this hypoth-
sis is that several factors, such as obesity, sympathetic
ervous system stimulation, increased uric acid, and endo-
helial dysfunction, result in preglomerular arteriosclerosis
nd tubulointerstitial disease. As the arteriosclerosis devel-
ps, persistent local renal vasoconstriction, ischemia, and
nflammation occur, with subsequent release of renin from
uxtaglomerular cells around the afferent arteriole (3). Con-
equently, the renin-angiotensin system is up-regulated, and
lood pressure is increased (3,4).
Atherosclerosis is a chronic reparative inflammatory pro-
ess that proceeds through a sequence of pathophysiologic
teps and is the result of injurious stimuli to the endothe-
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ccepted July 16, 2007.ium of the arterial wall (5,6). Risk factors for atherosclerosis
re similar to those for preglomerular arteriosclerosis and
nclude high levels of low-density lipoprotein (LDL) cho-
esterol, high blood pressure, cigarette smoking, diabetes/
besity, and a family history of premature coronary heart
isease (CHD) (7). Furthermore, studies indicate that
therosclerosis affects not only the larger conduit vessels, but
lso smaller arterioles (8–10).
Classic histologic studies have demonstrated that calcium
s deposited during the process of atherosclerosis (5,11,12).
xidized LDL cholesterol in the intima of the arterial wall
esults in inflammation and recruitment of activated mac-
ophages to the endothelium, which propagates the inflam-
atory process (5,6). This includes morphologic and phys-
ologic changes in medial smooth-muscle vascular cells that
articipate in vascular calcification. Once the lipid core is
ormed, calcium granules appear (type IV lesion). With
rogression to type V atherosclerotic lesions, lumps or plates
f calcium are formed and, eventually, calcium is the
redominant component of advanced lesions (11,12). These
alcified plaques can be detected in many vascular beds and
uantified by computed tomography (CT) (13). The extent
f calcified atheromatous plaque found on CT is a valid and
eproducible measure of the total atherosclerotic plaque
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given vascular bed is only modestly correlated with the
egree of luminal stenosis (14,15). Importantly, previous
tudies have demonstrated calcium in the coronary arteries
o be a significant and independent predictor of future
ardiovascular disease (CVD) events (16–20).
We hypothesized that the presence and extent of calcified
therosclerosis in the renal arteries is a surrogate marker for
reglomerular atherosclerosis and would be significantly associ-
ted with HTN. Accordingly, in a population free of clinical
VD, the aim of the present study was to determine the
agnitude and significance of any association between renal
rtery calcium (RAC) and both blood pressure levels and a
iagnosis of HTN.
Because the majority of cases of HTN are classified as
essential” or idiopathic (4), detection of calcium in the
enal arteries may provide clinical information on the
pecific etiology for an individual patient. The presence of
AC may also be clinically important for detection of those
t increased risk for concomitant CVD in other vascular
reas. In support of this hypothesis, we have recently found
trong and significant correlations between RAC and cal-
ium in the coronaries, carotids, thoracic aorta, abdominal
orta, and iliac arteries, as well as the aortic and mitral
nnuli (21).
aterials and Methods
ubjects. From February 1, 2001, to June 29, 2001, 1,461
onsecutive patients were evaluated by electron beam com-
uted tomography (EBCT) at a university-affiliated disease
revention center in San Diego, California, for the extent of
alcified atherosclerosis in 5 different vascular beds: the
arotid, coronary, thoracic aorta, abdominal aorta, and iliac
essels. This is a clinical population where subjects either
elf-referred or were referred on the recommendation of
heir personal physician as an adjunct to their preventive
ealth care. Previous results from this cohort have been
ublished (22–27). For the current study, we excluded
ndividuals with a history of clinical CVD (myocardial
nfarction, stroke, transient ischemic attack, angina, coro-
ary revascularization [coronary artery bypass grafting, an-
ioplasty, or stenting]), or carotid artery surgery.
All study data were collected at the same patient visit.
articipants completed a detailed health history question-
aire that collected information on history of HTN, diabe-
es, high cholesterol, smoking, family history of CHD,
edications, diet, exercise, and prior surgeries. After the
atient had rested for 5 min in the seated position, and
sing a standardized protocol, trained technicians obtained
ystolic and diastolic blood pressures in the right upper
xtremity by automated oscillometry. Casual serum total,
igh-density lipoprotein (HDL) and LDL cholesterol, and
lucose measurements were obtained by fingerstick using
he Cholestech LDX system (Cholestech, Hayward, Cali-
ornia). Body mass index (BMI) was calculated with the vatient lightly clothed (without
hoes). Body fat measurement
as conducted using bioimpe-
ence (Omron HBF-300, Om-
on, Schaumburg, Illinois).
Hypertension was defined as a
ystolic blood pressure (SBP) or
iastolic blood pressure (DBP)
140 or 90 mm Hg respec-
ively, or self-report of physician-
iagnosed HTN and current use
f an antihypertensive medication
angiotensin-converting enzyme
nhibitors, angiotensin II receptor
lockers, alpha- and beta-blockers,
alcium channel blockers, diuret-
cs, or combination agents). Mean
rterial pressure (MAP) was calcu-
ated using the following equation:
AP  DBP  1/3(SBP 
BP). Pulse pressure (PP) was the
ifference between systolic and diastolic blood pressures.
moking status was defined as current, former or never.
iabetes was defined by current use of physician-prescribed
ntiglycemic medications or a glucose 200 mg/dl (28).
ndividuals with a total-to-HDL cholesterol ratio 5 or who
eported using a medication for high cholesterol were classified
s dyslipidemic (29–32). The study protocol was approved by
he Human Research Protection Program at the University of
alifornia at San Diego, which granted a waiver of informed
onsent.
maging. Imaging was conducted using an Imatron C-150
canner (General Electric, San Francisco, California). Im-
ges for each vascular bed were obtained from a single scan
sing 100-ms scan time and proceeding caudally from the
ase of the skull to the symphysis pubis. Each bed was
btained by a distinct scan of the segment in question
mploying the following slice thicknesses: 3 mm for the
oronary bed; 5 mm for the thorax; and 6 mm through the
eck, abdomen, and pelvis. Cardiac tomographic imaging
as electrocardiographically triggered at 40% or 65% of the
-R interval, depending on the subject’s heart rate. Imaging
f the heart, thorax, and abdomen was conducted during
eparate breath holds at one-half–maximal inspiration.
Atherosclerotic calcium was defined as a plaque area
1 mm2 with a density of 130 Hounsfield units (HU).
uantitative calcium scores were determined according
o the method described by Agatston et al. (13). In brief,
he calcium score per lesion was calculated by multiplying
he area of the contiguous pixels by the corresponding
ensity number using the following scale for density (1 
30 to 199 HU, 2  200 to 299 HU, 3  300 to 399 HU,
 400 HU). The total calcium score was then
etermined by summing the lesion scores from all of the
lices for that segment. Agatston calcium scores for
Abbreviations
and Acronyms
CT  computed
tomography
CVD  cardiovascular
disease
DBP  diastolic blood
pressure
HDL  high-density
lipoprotein
HTN  hypertension
LDL  low-density
lipoprotein
MAP  mean arterial
pressure
PP  pulse pressure
RAC  renal artery calcium
SBP  systolic blood
pressureascular beds other than the coronaries were adjusted for
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Hypertension and Renal Artery Calcium October 16, 2007:1578–83lice thickness using the following formula: adjusted
core original score slice thickness/3.0. Volume averaging
as avoided by scoring each homogeneous slice thickness
egment separately.
Using the Agatston method for calcium scoring and the
ame software used for scoring the vascular beds, image files
f the abdomen were retrospectively interrogated for the
resence and extent of calcium in both renal arteries (33).
uring scoring, calcium in these arteries was categorized as
rising from the ostia or arterial segment proper. Calcium in
he wall of the abdominal aorta was not included in the
ssessment for RAC by excluding any visible calcium in the
xtrapolated plane of the aorta at the renal artery origin.
he total amount of calcium in the renal arteries was
alculated as the sum of the ostial and arterial segments.
he reader for RAC viewed only images that contained the
enal arteries, and this individual was blinded to the scores
or the other beds.
tatistical analysis. The level of significance for this study
as 0.05 (2-tailed). Tests for group differences for those
ith and without any renal calcium were conducted using
nalysis of variance or the Kruskal-Wallis test (as appropri-
te) for continuous variables and the chi-square test for
ategorical variables. Mean risk factor values by RAC group
ere adjusted for age and gender using analysis of covari-
nce. The potential association between the presence of
AC and HTN was explored by multivariable logistic
egression (34). These models were conducted unadjusted
nd then adjusted for the traditional CVD risk factors and
he extent of nonrenal vascular calcium.
esults
fter exclusions for prevalent CVD, the total number of
Cohort Characteristics Stratified by the Presenc
Table 1 Cohort Characteristics Stratified by
Variable
Age (yrs), mean (SD)*
Female, n (%)†
BMI (kg/m2), mean (SD)‡
Total body fat (%), mean (SD)‡
Ever smoker, n (%)‡
Diabetes mellitus, n (%)‡
Total cholesterol‡
LDL cholesterol‡
HDL cholesterol‡
Dyslipidemia, n (%)‡
Hypertension, n (%)‡
Family history of CHD, n (%)‡
Carotid calcium score, median (interquartile range)
Coronary calcium score, median (interquartile range)
Thoracic aorta calcium score, median (interquartile range)
Abdominal aorta calcium score, median (interquartile range
Iliac calcium score, median (interquartile range)
*Adjusted for gender. †Adjusted for age. ‡Adjusted for age and gend
BMI bodymass index; CHD coronary heart disease; HDL high-dubjects available for analysis was 1,435. The overall prev- mlence of calcium in either renal artery was 17.1%, with men
aving a significantly higher prevalence (19.0%, 153 of 804)
han women (14.7%, 93 of 631, p  0.03). Because of the
igh number of subjects with no RAC, the distributions of
hese variables were highly right-skewed. Accordingly, the
edian RAC score was 0, with a minimum of 0 and a
aximum of 779. The overall prevalence of HTN in this
ohort was 25.6%.
The characteristics of the cohort stratified by the presence
nd absence of RAC are provided in Table 1. Those with
ny RAC were significantly older (72.5 vs. 58.6, p  0.01),
ith a significantly higher proportion of men (65.7 vs.
4.0%, p  0.01). Those with a RAC score 0 had
ignificantly higher median calcium scores in the carotid,
oronary, thoracic and abdominal aorta, and the iliac arter-
es. After adjustment for age and gender, subjects with a
AC score 0 had a significantly higher prevalence of
TN but not diabetes, dyslipidemia, or smoking; a family
istory of CHD was of borderline significance. Although
ot collected specifically for this study, subsequent assessment
f the ethnic distribution of patients presenting at the clinic
howed that nearly all (90%) were non-Hispanic white.
In the RAC0 group, the mean SBP was 127.8 mm Hg,
ompared with 125.6 mm Hg in the RAC  0 group.
lthough this difference was small and not statistically
ignificant (p  0.12), it underestimated the SBP-RAC
ssociation, as there were essentially 3 times as many blood
ressure medication users in the RAC 0 group as in the
AC  0 group (25.1% vs. 8.6%, p  0.01). Furthermore,
fter adjustment for age and gender, the mean systolic and
iastolic blood pressures were significantly higher in those
ypertensive patients receiving medications compared with
hose who were not hypertensive (systolic: 131.9 vs. 119.8
RAC
Presence of RAC
AC >0 (n  246) RAC  0 (n  1,189) p Value
72.5 (8.8) 58.6 (10.0) 0.01
90 (34.3) 552 (46.0) 0.01
25.1 (4.4) 25.9 (4.6) 0.13
28.6 (8.9) 29.1 (8.4) 0.44
125 (50.8) 537 (45.2) 0.15
9 (3.8) 26 (2.2) 0.18
78.8 (75.4) 178.8 (72.3) 0.99
97.2 (55.1) 96.7 (53.5) 0.90
44.5 (23.8) 46.5 (23.9) 0.26
78 (31.8) 326 (27.4) 0.20
101 (41.2) 351 (29.5) 0.01
75 (30.6) 286 (24.1) 0.06
89 (0–372) 0 (0–0) 0.01
222 (31–769) 1.6 (0–47) 0.01
510 (134–1,496) 0 (0–39) 0.01
,484 (490–3,505) 0 (0–187) 0.01
,103 (150–3,013) 2 (0–199) 0.01
lipoprotein; LDL low-density lipoprotein; RAC renal artery calcium.e of
the
R
1
) 1
1m Hg; diastolic: 82.0 vs. 76.5 mm Hg; p 0.01 for both).
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October 16, 2007:1578–83 Hypertension and Renal Artery CalciumWe further explored the association between RAC and
TN by examining whether there were differences in both
he number and types of blood pressure medications be-
ween the RAC groups. Compared to the RAC  0 group,
here were higher prevalences of single (16.7% vs. 6.3%) and
ultiple (8.4% vs. 2.3%) medication use in the RAC 0
roup (p  0.01 for both). These differences remained
ignificant after adjustment for age and gender. There was
lso a significantly higher prevalence of angiotensin-
onverting enzyme inhibitor (11.0% vs. 2.9%), angiotensin
eceptor blocker (3.4% vs. 0.9%), beta-blocker (8.7% vs.
.0%), and diuretic (3.8 vs. 1.2%) use in the RAC0 group
ompared to the RAC  0 group (p  0.05 for all). With
djustment for age and gender, all of these differences
emained statistically significant except for diuretics, which
as of borderline significance (p  0.06).
The results of logistic regression analyses assessing the
agnitude of association between prevalent RAC and being
lassified with HTN are shown in Figure 1. There was no
ignificant interaction between gender and RAC for HTN.
fter adjustment for age and gender, the odds ratio (OR)
or HTN was 1.63 times higher in those with any RAC
ompared to those with none (p  0.01). Additional
djustment for BMI and percent body fat, as well as these
ariables plus smoking, diabetes, dyslipidemia, and family
istory of premature CHD, did not reduce the magnitude of
his association (OR 1.74 and 1.70, respectively; p 0.01
or both). With further adjustment for the extent of calcium
n the abdominal aorta, the association was only slightly
ttenuated and remained significant (OR 1.60, p 0.01).
hen abdominal aortic calcium was replaced by the total
mount of calcium in all of the nonrenal vascular beds, the
R was essentially unchanged (OR  1.61, p  0.01).
To further characterize the relationship between calcium
f the renal arteries and HTN, we compared the sensitivity,
pecificity, positive predictive value, negative predictive
Figure 1 Magnitude of Association Between
Prevalent Renal Artery Calcium and Hypertension
White bar  unadjusted; orange bar  age and gender; green bar  age, gen-
der, and cardiovascular disease (CVD) risk factors (RFs); blue bar  age, gen-
der, CVD RFs, and abdominal aortic calcium score; maroon bar  age, gender,
CVD RFs, and total extrarenal calcium score. Vertical bars  95% confidence
interval; p  0.05 for all models.alue, and accuracy in predicting the presence of HTN by
f
vhe presence/absence of calcium in the nonrenal vascular
eds versus the presence/absence of RAC (Table 2). Com-
ared to the presence of calcium in the carotids, coronaries,
horacic aorta, abdominal aorta, or iliacs, any RAC was
ssociated with the highest specificity (86.2%), positive
redictive value (40.2%), and, most importantly, overall
ccuracy (71.2%) for the presence of HTN, despite having
he lowest sensitivity.
iscussion
n this large cross-sectional study of individuals free of
linical CVD, and after adjustment for the traditional CHD
isk factors and the extent of calcium in the systemic
asculature, the presence of any RAC was significantly
ssociated with more than 60% higher odds of having
TN. Furthermore, compared with the presence of calcium
n other vascular beds, the presence of any RAC provided
he highest overall accuracy for correctly distinguishing
hose who had HTN at the time of their EBCT scan. To
ur knowledge, this is the first report of a significant
ssociation between calcium of the renal arteries determined
y CT and HTN.
After adjustment for age, gender, and blood pressure
edication status, there were no significant differences in
he levels of SBP, DBP, PP, or MAP between those who
id and did not have any RAC. Notably, among those
eceiving a blood pressure medication, the levels of these
arameters were nearly identical for those with any RAC
nd those with no RAC (133.1 vs. 133.0, p  0.96; 81.1 vs.
1.9, p  0.83; 51.7 vs. 51.1, p  0.83; 98.6 vs. 98.9, p 
.90; respectively). Conversely, the levels among those not
eceiving a blood pressure medication were consistently
igher (126.9 vs. 124.7, p  0.13; 80.4 vs. 79.2, p  0.27;
6.5 vs. 45.4, p  0.35; 95.9 vs. 94.4, p  0.16; respec-
ively). These results demonstrate control of blood pressure
o a similar level by blood pressure medication regardless of
AC status while, at the same time, the consistently higher
alues, as well as larger differences among those not receiv-
ng a blood pressure medication, suggest that RAC may be
ssociated with higher blood pressure levels and that the
elationships Between Calciumn Different Vascular Beds and HTN
Table 2 Relationships Between Calciumin Different Vascular Beds and HTN
Disease: HTN (Yes vs. No)
“Exposure”: Calcium in a Vascular Bed (Any vs. None)
Vascular Bed Sensitivity Specificity PPV NPV Accuracy
Renals 27.0 86.2 40.2 77.5 71.2
Carotids 43.7 71.9 34.8 78.9 64.7
Coronaries 75.7 45.3 32.1 84.5 53.0
Thoracic aorta 52.7 60.2 31.2 78.8 58.3
Abdominal aorta 71.6 47.1 31.7 82.9 53.4
Iliacs 68.9 47.7 28.8 81.7 53.1
ccuracy  (true positives  true negatives)/(true positives  false positives  true negatives 
alse positives); HTN  hypertension; NPV  negative predictive value; PPV  positive predictive
alue.
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Hypertension and Renal Artery Calcium October 16, 2007:1578–83ignificant association between RAC and prevalent HTN is
argely driven by those receiving blood pressure medications.
Approximately 90% of renal artery stenosis cases are due
o atherosclerosis (35). This condition results in an increase
n preglomerular arterial resistance that is proportional to
he degree of the stenosis and causes a decrease in renal
lood flow. This may cause a secondary increase in systemic
rterial pressure attributable to either increased renin secre-
ion and angiotension formation or activation of afferent
enal sympathetic nerves because of the renal baroreceptor
esponse. However, the association between HTN and
therosclerotic renal artery stenosis is complex because
enovascular HTN is not a necessary consequence of this
isease (35). Furthermore, split renal function studies show
hat in patients with impaired renal function and unilateral
onocclusive renal artery stenosis, the kidney with the
onstenosed artery is just as likely to have impaired function
s the one with renal artery stenosis (36). These results
uggest that factors other than the degree of luminal stenosis
ay be influencing blood pressure regulation.
Because RAC is very modestly related to the degree of
tenosis in these arteries (14) and other studies have shown
hat calcium attributable to atherosclerosis is more highly
orrelated with total plaque burden than the severity of
tenosis (37), the results of our study suggest that the burden
f subclinical atherosclerosis in the renal arteries may be
inked to the kidney’s influence on blood pressure. Addi-
ionally, because RAC was significantly associated with
TN after adjustment for the extent of atherosclerosis in
ther vascular beds, it appears that the local effects of
therosclerosis on renovascular HTN may be independent
f the CVD risk factors and the systemic burden of
therosclerosis as reflected by calcium in the other (nonre-
al) vascular beds.
The presence of RAC may also be clinically important for
etection of those at increased risk for concomitant CVD in
ther vascular areas. In support of this hypothesis, we have
ecently found (21) strong and significant correlations be-
ween RAC and calcium in the coronaries, carotids, thoracic
orta, abdominal aorta and iliac arteries, as well as the aortic
nd mitral annuli. Furthermore, it is generally acknowl-
dged that the risk factors for coronary artery disease
CAD) and atherosclerotic renal artery stenosis are similar
38,39). Additionally, the mortality of patients with CAD and
therosclerotic renal artery stenosis is doubled compared with
atients with suspected CAD undergoing catheterization
41,42). Notably, the literature on subclinical atherosclerosis in
he renal arteries is quite modest; therefore, further research
nto the potential association between RAC and CVD is
ecommended.
This report is based on data from a cross-sectional study
esign. Therefore, it is possible that reverse causality (i.e.,
TN resulting in RAC) is responsible for the significant
ssociation between RAC and HTN. Indeed, HTN has
een shown to be a risk factor for RAC (43) as well asalcified atherosclerosis in other vascular beds (26,27).
owever, we believe the evidence suggests that RAC is also
risk factor HTN. Specifically, we found that RAC was
uch more specific for HTN that calcified atherosclerosis
n the other (nonrenal) vascular beds. Also, although the
umbers are small, compared to patients with no calcium in
ny of the vascular beds, and after adjustment for age,
ender, and CVD risk factors, those with calcium only in
he renal arteries had nearly a 7-fold higher odds for the
resence of HTN, whereas those with calcium limited to
he nonrenal vasculature had only 2-fold odds for HTN.
inally, in our analyses the association between RAC and
TN was adjusted for the extent of calcified atherosclerosis
n the nonrenal vasculature. Because HTN is a significant
isk factor for calcified atherosclerosis, inclusion of nonrenal
alcium in the multivariable models should account for
ome (but likely not all) of the confounding due to HTN. A
rospective study is underway to further investigate the
ssociation between RAC and HTN.
tudy limitations. Patients in this study were either self-
eferred or referred on the advice of their personal physician.
ypically, these individuals tend to be from higher socio-
conomic status and more concerned with health-related
ssues and therefore are probably engaged in more preven-
ive health strategies. Also, the study population was free of
linical CVD. Therefore, the sample for this study may not
e representative of the general population or populations
rom community-based samples, and the results of this
tudy may not be generalizable to those groups. This study
mployed only a single measure of blood pressure. This may
ead to misclassification with respect to HTN. In this case,
he misclassification would not be systematic, and, therefore
he association between RAC and HTN would be under-
stimated. Also, the association between RAC and HTN
as largely driven by the inclusion of those individuals who
ere taking blood pressure medications. Notably, the prev-
lence of HTN in this study was similar to that for the U.S.
opulation (44). Because the definition of diabetes in this
tudy relied on self-report of medication use for this
ondition and not a fasting plasma glucose, there is the
otential for misclassification. Calcium detected by EBCT
s primarily due to intimal changes associated with athero-
clerosis. However, this technique does not distinguish
etween intimal calcium due to atherosclerosis and
ockeberg’s medial calcinosis. Because the latter occurs
rincipally in those with diabetes (45) or chronic kidney
isease (46) and is located primarily in the lower extremities
below the knee), we believe the probability of misclassifi-
ation is low in our study.
eprint requests and correspondence: Dr. Matthew A. Allison,
855 Health Sciences Drive, Mailcode 0817, La Jolla, California
2093-0817. E-mail: mallison@ucsd.edu.
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